Clinical Trial Update: SPT Screening in Irradiated Hereditary Retinoblastoma Survivors

View source ↗

Summary

This entry reports an update on a clinical trial evaluating SPT screening in irradiated hereditary retinoblastoma survivors, sponsored by Amsterdam UMC (VUmc), …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinoblastoma

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Retinoblastoma | Status: UNKNOWN